ilaprazole has been researched along with dexlansoprazole in 1 studies
| Studies (ilaprazole) | Trials (ilaprazole) | Recent Studies (post-2010) (ilaprazole) | Studies (dexlansoprazole) | Trials (dexlansoprazole) | Recent Studies (post-2010) (dexlansoprazole) |
|---|---|---|---|---|---|
| 53 | 24 | 42 | 88 | 38 | 57 |
| Protein | Taxonomy | ilaprazole (IC50) | dexlansoprazole (IC50) |
|---|---|---|---|
| WD repeat-containing protein 5 | Homo sapiens (human) | 5.7 | |
| Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 5.7 | |
| NAD(+) hydrolase SARM1 | Homo sapiens (human) | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, EH; Kim, HY; Lee, SK; Park, CH; Roh, YH | 1 |
1 review(s) available for ilaprazole and dexlansoprazole
| Article | Year |
|---|---|
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Magnesium; Odds Ratio; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Risk Factors; Treatment Outcome | 2014 |